BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8590866)

  • 1. Granulocyte colony-stimulating factor in acute myeloid leukemia.
    Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
    Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
    Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the proliferative response to granulocyte colony-stimulating factor and the positivity of transferrin receptor in acute myeloblastic leukemia cells.
    Motoji T; Mineshima M; Watanabe M; Takanashi M; Masuda M; Oshimi K; Mizoguchi H
    J Cell Physiol; 1991 Sep; 148(3):421-5. PubMed ID: 1717498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).
    Wörmann B; Hiddemann W; Frisch J; Zühlsdorf M; Rottmann R; Boeckmann A; Reuter C; Freire EA; Innig G; Schulz G
    Behring Inst Mitt; 1991 Dec; (90):28-38. PubMed ID: 1801688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of granulocyte-macrophage colony-stimulating factor and interleukin 6 on the growth of leukemic blasts in suspension culture.
    Tsao CJ; Cheng TY; Chang SL; Su WJ; Tseng JY
    Int J Cell Cloning; 1992 May; 10(3):166-72. PubMed ID: 1613267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor binding of human granulocyte colony-stimulating factor to the blast cells of myeloid leukemia.
    Piao YF; Okabe T
    Cancer Res; 1990 Mar; 50(6):1671-4. PubMed ID: 1689609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the chimeric soluble granulocyte colony-stimulating factor receptor on the proliferation of leukemic blast cells from patients with acute myeloblastic leukemia.
    Asano Y; Yokoyama T; Shibata S; Kobayashi S; Shimoda K; Nakashima H; Okamura S; Niho Y
    Cancer Res; 1997 Aug; 57(16):3395-7. PubMed ID: 9270003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
    Takahashi S; Okamoto SI; Shirafuji N; Ikebuchi K; Tani K; Shimane M; Matsudaira T; Irie S; Tsuruta T; Matsuishi E
    Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human G-CSF and GM-CSF on primary human leukemic cells.
    Itoh K; Bessho M; Hirashima K
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):988-95. PubMed ID: 2480049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
    Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
    Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
    Notario A; Rolandi ML; Mazzucchelli I
    Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction.
    Lanza F; Rigolin GM; Castagnari B; Moretti S; Castoldi G
    Haematologica; 1997; 82(2):239-45. PubMed ID: 9175331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
    Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
    Chen J; Zhou JH; Ball ED
    Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia.
    Wörmann B; Reuter C; Zühlsdorf M; Büchner T; Hiddemann W
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):39-43. PubMed ID: 7801145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells.
    Bendall LJ; Daniel A; Kortlepel K; Gottlieb DJ
    Exp Hematol; 1994 Dec; 22(13):1252-60. PubMed ID: 7957711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.
    Frankel AE; Powell BL; Hall PD; Case LD; Kreitman RJ
    Clin Cancer Res; 2002 May; 8(5):1004-13. PubMed ID: 12006512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.